Single Doses GSK159797 On Patient Safety And Lung Function In Patients With Mild To Moderate Asthma
Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
This study was designed to test safety aspects and effects on lung function of a new dry
powder version of GSK159797 for asthmatic subjects to inhale. This will allow comparison with
previous studies which have only used inhalation of the drug as a vapour.